Mortality factors in recurrent parathyroid cancer: a pooled analysis

被引:8
作者
Tsai, Wen-Hsuan [1 ]
Zeng, Yi-Hong [1 ,2 ]
Lee, Chun-Chuan [1 ,2 ]
Tsai, Ming-Chieh [1 ,2 ]
机构
[1] Mackay Mem Hosp, Dept Endocrinol, Dept Internal Med, Div Endocrinol & Metab, 92,Sec 2,Zhongshan N Rd, Taipei 104, Taiwan
[2] MacKay Med Coll, Dept Med, New Taipei, Taiwan
关键词
Parathyroid cancer; Recurrence; Bone metastasis; Prognostic factor; PULMONARY METASTASES; TELOMERASE ACTIVITY; PROGNOSTIC-FACTORS; CARCINOMA; DIAGNOSIS; HYPERCALCEMIA; MANAGEMENT; PATIENT; PARAFIBROMIN; SURGERY;
D O I
10.1007/s00774-021-01305-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Parathyroid cancer is a rare disease with high recurrence rate. The prognostic factors for recurrent parathyroid cancer are yet to be ascertained. We aimed to establish the association between recurrent parathyroid cancer and previously reported prognostic factors. Materials and methods We conducted a PubMed search using the keywords 'parathyroid cancer', 'parathyroid neoplasm', and 'hypercalcemia' during 1966-2019 and included 3272 articles. We focused on 73 patients with recurrent parathyroid cancer from 55 studies. We conducted a survival analysis using the Cox proportional hazards model with 95% confidence interval. Results For the 73 patients included in the analysis, the mean age (+/- standard deviation) was 44 +/- 13.2 years, wherein 36 patients were women (49.3%). During the 5236 person-months at risk (mean follow-up 71.7 months, range 3-264), 38 patients died. The incidence of local recurrence, lymph-node metastasis, lung metastasis, and bone metastasis were 60.3, 12.3, 56.2, and 24.7, respectively. Bone metastasis, disease-free interval < 1 year, and total surgeries < 3 were significant prognostic factors in univariate analysis (log-rank test P = 0.0063, P = 0.0006, and P = 0.0056, respectively). In the multivariate-adjusted analysis, the mortality risk was significantly increased in patients with bone metastasis with a hazard ratio (HR) of 4.83 (95% CI 1.16-20.2; P = 0.03), disease-free interval <=1 year of 5.92 (95% CI 1.85-18.99; P = 0.003), and total surgeries <3 of 11.29 (95% CI 2.82-45.22; P = 0.001), considering these as possible predictive prognostic factors. Conclusion Bone metastasis, duration of disease-free interval, and total number of surgeries predict survival in recurrent parathyroid cancer.
引用
收藏
页码:508 / 517
页数:10
相关论文
共 50 条
  • [31] Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience
    Wei, Bojun
    Zhao, Teng
    Shen, Hong
    Jin, Mulan
    Zhou, Quan
    Liu, Xing
    Wang, Jiacheng
    Wang, Qian
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (02) : 1208 - 1215
  • [32] Prognostic Factors for Survival in Patients With Recurrent Cervical Cancer Previously Treated With Radiotherapy
    Mabuchi, Seiji
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Temma, Kumiko
    Takeda, Takashi
    Yamamoto, Toshiya
    Enomoto, Takayuki
    Morishige, Kenichirou
    Inoue, Takehiro
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 834 - 840
  • [33] Is parathyroid hormone a viable solution for nonunion? a systematic review and pooled analysis
    Kim, Seung-Ju
    Park, Hyun-Soo
    Lee, Dong-Woo
    Lee, Jae-Won
    ACTA ORTHOPAEDICA BELGICA, 2017, 83 (04): : 527 - 535
  • [34] Surgical management of recurrent parathyroid cyst
    Lassaletta, L
    Bernáldez, R
    García-Pallarés, M
    Morera, E
    AURIS NASUS LARYNX, 2002, 29 (01) : 83 - 85
  • [35] Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence
    Kim, Ekaterina I.
    Eremkina, Anna K.
    Elfimova, Alina R.
    Mokrysheva, Natalia G.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (10) : 958 - 967
  • [36] Recurrent Ovarian Cancer: The Role of Radiation Therapy
    De Felice, Francesca
    Marchetti, Claudia
    Di Mino, Andrea
    Palaia, Innocenza
    Benevento, Ilaria
    Musella, Angela
    Musio, Daniela
    Tombolini, Vincenzo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 690 - 695
  • [37] Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer
    Pfannschmidt, Joachim
    Hoffmann, Hans
    Dienemann, Hendrick
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S172 - S178
  • [38] Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model
    Salah, S.
    Watanabe, K.
    Welter, S.
    Park, J. S.
    Park, J. W.
    Zabaleta, J.
    Ardissone, F.
    Kim, J.
    Riquet, M.
    Nojiri, K.
    Gisabella, M.
    Kim, S. Y.
    Tanaka, K.
    Ali, B. Al-Haj
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2649 - 2655
  • [39] Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study
    Lee, Sae Byul
    Sohn, Guiyun
    Kim, Jisun
    Chung, Il Yong
    Lee, Jong Won
    Kim, Hee Jeong
    Ko, Beom Seok
    Son, Byung Ho
    Ahn, Sei-Hyun
    BREAST CANCER, 2018, 25 (06) : 639 - 649
  • [40] Pooled analysis of the surgical treatment for colorectal cancer liver metastases
    Veereman, G.
    Robays, J.
    Verleye, L.
    Leroy, R.
    Rolfo, C.
    Van Cutsem, E.
    Bielen, D.
    Ceelen, W.
    Danse, E.
    De Man, M.
    Demetter, P.
    Flamen, P.
    Hendlisz, A.
    Sinapi, I.
    Vanbeckevoort, D.
    Ysebaert, D.
    Peeters, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 122 - 135